每年更新FDA 要求: • 1) 注册和登记每年要更新一次(更新时间是:10月1号到12月31号 • 2) 要随时通知FDA注册和登记内容的变化。 – II 类产品,在进行设施登记和器械注册后,还需递交“上市前通知” 即510(K)申请。只有个别产品510(K) 豁免。
![FDA美国代理人](http://static.11467.com/img/lazy.gif)
检查结果: 1.没有书面评价,这是好的情况; 2.轻微项的483表,或一封感谢信; 3.有批评的483表,它可能会导致:1)Seizure(查封)2)Detention(扣押)3)Restraining Orders and Injunctions(强制停产)4)Penalties(罚款)5)Recall(撤回) 4. Waring letter(警告信)审核重点:对于不同的产品,审核的重点不一样的
![FDA美国代理人](http://static.11467.com/img/lazy.gif)
提供FDA注册,食品FDA注册、化妆品FDA注册,美国代理人服务、FDA验厂、FDA警告性移除
![FDA美国代理人](http://static.11467.com/img/lazy.gif)
Responsibilities of a U.S. agent The U.S. agent must either reside in the U.S. or maintain a place of business in the U.S. The U.S. agent cannot use a post office box as an address. The U.S. agent cannot use an answering service. They must be available to answer the phone or have an employee available to answer the phone during normal business hours. The responsibilities of the U.S. agent are limited and include: assisting FDA in communications with the foreign establishment, responding to concerning the foreign establishment's devices that are imported or offered for import into the United States, assisting FDA in scheduling inspections of the foreign establishment and if FDA is unable to contact the foreign establishment directly or expeditiously, FDA may provide information or documents to the U.S. agent, and such an action shall be considered to be e to providing the same information or documents to the foreign establishment. Please note that the U.S. agent has no responsibility related to reporting of adverse events under the Medical Device Reporting regulation (21 CFR Part 803), or submitting 510(k) Premarket Notifications (21 CFR Part 807, Subpart E).